Skip to main content

AZB & Partners and Cleary Gottlieb Steen & Hamilton have advised GlaxoSmithKline (GSK) on the $3.4 billion sale of its entire stake in India’s Hindustan Unilever, with Latham & Watkins representing the placement agents.

According to Reuters, this marks India’s largest secondary market block trade, and the tenth-largest globally. GSK, which owned a 5.7 percent stake in Hindustan Unilever is looking to split into two entities. 

The AZB team was led by partners Vinati Kastia, Daksh Trivedi, Ajay Bahl and Ankit Tandon.

A Latham & Watkins team led by partners Rajiv Gupta and Jiyeon Lee-Lim advised Morgan Stanley India Company, J.P. Morgan India and HSBC Securities and Capital Markets (India).

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

CAM, Trilegal, Khaitan, IndusLaw act on HUL’s $350 mln Minimalist deal

by Nimitt Dixit |

In the first big M&A deal in India this year, leading firm Cyril Amarchand Mangaldas has guided FMCG major Hindustan Unilever (HUL) on its acquisition of 90.5 percent stake in Jaipur-based skincare startup Minimalist for close to $350 million (29.5 billion rupees).

Deals

7 international, Indian firms act on Kedaara Capital’s $350 mln U.S. bet

by Nimitt Dixit |

Akin Gump Strauss Hauer & Feld, Quillon Partners, and Kelley Drye & Warren have advised Indian private equity firm Kedaara Capital on its maiden bet in the data analytics and AI solutions market, committing $350 million strategic investment to San Jose, California-based Impetus Technologies.

Deals

SAM, Latham guide Hexaware’s upcoming $1.2 bln India IPO

by Nimitt Dixit |

Indian law firm Shardul Amarchand Mangaldas & Co has been mandated to assist Hexaware Technologies, an AI-focused tech company backed by Carlyle Group, on its upcoming initial public offering (IPO) in India, which is expected to raise $1.2 billion.